Country: Malta
Language: English
Source: Medicines Authority
CARBENOXOLONE SODIUM
Rowa Pharmaceuticals Limited Newtown, Bantry, Co. Cork, Ireland
A01AB11
CARBENOXOLONE SODIUM 100 mg
GEL
CARBENOXOLONE SODIUM 100 mg
OTC
STOMATOLOGICAL PREPARATIONS
Authorised
2005-05-31
Read the complete document
Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Carbosan 2% w/w Gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 g of Carbosan Gel contains 100 mg Carbenoxolone Sodium. Excipients: contains 0.30% w/w parahydroxybenzoic acid esters, sodium salt. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gel A translucent, colourless gel with a lemon odour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Carbosan Gel is indicated in the symptomatic relief and treatment of lip sores, mouth ulcers or aphthous changes in the oral mucous membranes. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of Administration: Cutaneous RECOMMENDED DOSAGE SCHEDULE: Adults and children over 3 years only: Apply thickly to lesions after meals and at bedtime. Page 2 of 4 4.3 CONTRAINDICATIONS Carbosan Gel is contra-indicated in patients suffering from severe cardiac, renal and hepatic impairment, patients with hypertension or those who are receiving cardiac glycosides. Carbosan Gel is contra-indicated in elderly patients and in those patients who have low serum albumin. Carbosan Gel is also contra-indicated during pregnancy and lactation. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If bacterial infection is superimposed, appropriate therapy should be instituted. If symptoms persist for more than 2 weeks consult your doctor. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Carbosan Gel should not be used by patients who are receiving cardiac glycos Read the complete document